CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Investor Relations  /  Stock Exchange Disclosures  /  Other Announcements & Disclosures

OTHER ANNOUNCEMENTS & DISCLOSURES

May-21
19-MayInvestor Presentation – Q4 FY-21
03-MayChange in the name and contact details of Key Managerial Personnel under the Policy for Determination of Materiality for Disclosures.
Apr-21
28-Apr Change in Key Managerial Personnel of the Company.
28-AprAllotment of equity shares to Biocon India Limited Employee Welfare Trust under Biocon Restricted Stock Unit Long Term Incentive Plan FY 2020-24.
28-AprOutcome of Board Meeting – Financial Results for the quarter and year ended March 31, 2021
24-Apr Annual Secretarial Compliance Report
01-AprInvestor Presentation – Q3 FY-21
Mar-21
19-MarIntimation for Incorporation of Wholly Owned Subsidiary Company
08-MarDisclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’).
Jan-21
21-JanOutcome of Board Meeting – Financial Results Q3 FY21 for the quarter and nine months ended December 31, 2020
Dec-20
09-DecDisclosure pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’)
Oct-20
22-OctOutcome of Board Meeting – Financial Results for the quarter and half year ended September 30, 2020
Sep-20
22-SepAppointment of Mr. Anupam Jindal as Chief Financial Officer and Step down of Mr. Indranil Sen as Interim CFO
03-SepAllotment of shares by BBIL to Tata Capital
Aug-20
21-AugIntimation pursuant to Regulation 30 of SEBI Listing Regulations, amendment in Memorandum of Association of the Company
Jul-20
25-JulVoting results and scrutinizers’ report of the 42nd Annual General Meeting (‘AGM’) of Biocon Limited (‘the Company’)
25-JulProceedings of the 42nd Annual General Meeting (‘AGM’) of Biocon Limited (‘the Company’)
23-JulOutcome of the Board Meeting
02-JulNotice of 42nd Annual General Meeting and the Annual Report for the FY 2019-20.
May-20
14-MayOutcome of the Board Meeting
14-MayAppointment of Interim Chief Financial Officer (‘Interim CFO’) and Key Managerial Personnel of the Company
Jan-20
23-Jan Outcome of the Board Meeting

FY: From April 1 – March 31

NOVEL BIOLOGICS
BIOSIMILARS
RESEARCH SERVICES
OUR CULTURE
BIOCON FOUNDATION
Share
Previous Next
Close
Test Caption
Test Description goes like this